Genomic epidemiology of circulating SARS-CoV-2 variants during first two years of the pandemic in Colombia
暂无分享,去创建一个
R. Bouckaert | K. Atkins | A. Drummond | S. Mattar | M. Muñoz | J. Ramírez | J. Douglas | Alfonso Calderón | Camilo Guzmán | J. Douglas | Nathalia Ballesteros | Sergio Castañeda | Angie L Ramírez | Nicolás Luna | A. Mondolfi | A. P. Paniz Mondolfi | Ricardo Rivero | Héctor Serrano-Coll | Bertha Gastelbondo | C. L. Jimenez Silva | R. Rivero | C. J. Villabona Arenas | B. Gastelbondo | A. Calderón | C. Guzmán | D. Echeverri-De la Hoz | N. Ballesteros | S. Castañeda | L. H. Patino | A. Ramirez | N. Luna | H. Serrano-Coll | C. Arenas | C. Jimenez Silva | Cinthy Lorena Jimenez Silva | Daniel Echeverri-De la Hoz
[1] M. Suchard,et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil , 2021, Science.
[2] L. Luo,et al. Transmission and containment of the SARS-CoV-2 Delta variant of concern in Guangzhou, China: A population-based study , 2022, PLoS neglected tropical diseases.
[3] A. Iafrate,et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity , 2021, Cell.
[4] Yuelong Shu,et al. GISAID: Global initiative on sharing all influenza data – from vision to reality , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[5] R. Bouckaert,et al. Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New Zealand , 2021, Emerging infectious diseases.
[6] An efficient coalescent epoch model for Bayesian phylogenetic inference , 2021, bioRxiv.
[7] L. Poon,et al. Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong , 2022, Nature communications.
[8] R. Neher,et al. Nextclade: clade assignment, mutation calling and quality control for viral genomes , 2021, J. Open Source Softw..
[9] J. Lopez Bernal,et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply. , 2021, The New England journal of medicine.
[10] M. V. Van Kerkhove,et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[11] H. Kishino,et al. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA , 2005, Journal of Molecular Evolution.
[12] D. A. Jackson,et al. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity , 2020, Cell.
[13] T. Choudhri,et al. Policy Interventions, Social Distancing, and SARS-CoV-2 Transmission in the United States: A Retrospective State-level Analysis , 2021, The American Journal of the Medical Sciences.
[14] Md. Rabiul Islam,et al. New Coronavirus Variants are Creating More Challenges to Global Healthcare System: A Brief Report on the Current Knowledge , 2022, Clinical pathology.
[15] O. Pybus,et al. Bayesian coalescent inference of past population dynamics from molecular sequences. , 2005, Molecular biology and evolution.
[16] N. Ajami,et al. Genomic epidemiology of SARS-CoV-2 in Colombia , 2020, medRxiv.
[17] S. Bhatt,et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.
[18] Gerardo del Cerro Santamaría,et al. Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2 , 2021, Infection, Genetics and Evolution.
[19] Edward C. Holmes,et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology , 2020, Nature Microbiology.
[20] M. Kraemer,et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa , 2021, Nature.
[21] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[22] Christiane,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.
[23] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[24] S. Eckstein. Ethical principles for medical research involving human subjects. , 2001, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[25] K. V. Parag,et al. Establishment & lineage dynamics of the SARS-CoV-2 epidemic in the UK , 2020, medRxiv.
[26] A. Paniz‐Mondolfi,et al. Impact of SARS‐CoV‐2 Mu variant on vaccine effectiveness: A comparative genomics study at the peak of the third wave in Bogota, Colombia , 2022, Journal of medical virology.
[27] Guangchuang Yu,et al. Using ggtree to Visualize Data on Tree‐Like Structures , 2020, Current protocols in bioinformatics.
[28] M. Ajelli,et al. Modeling transmission of SARS-CoV-2 Omicron in China , 2022, Nature Medicine.
[29] N. Alvis-Guzmán,et al. Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries? , 2020, Open forum infectious diseases.
[30] A. Ko,et al. Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu , 2022, medRxiv.
[31] N. G. Davies,et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 , 2021, Nature.
[32] Khalil Abudahab,et al. Microreact: visualizing and sharing data for genomic epidemiology and phylogeography , 2016, Microbial genomics.
[33] Elizabeth Weirich,et al. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel. , 2012, MMWR supplements.
[34] Korbinian Strimmer,et al. APE: Analyses of Phylogenetics and Evolution in R language , 2004, Bioinform..
[35] A. Kaneda,et al. Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum , 2021, The New England journal of medicine.
[36] N. Linton,et al. Serial interval of novel coronavirus (COVID-19) infections , 2020, International Journal of Infectious Diseases.
[37] D. Paredes-Sabja,et al. Evolution and Epidemic Spread of SARS-CoV-2 in Colombia: A Year into the Pandemic , 2021, Vaccines.
[38] S. Bonhoeffer,et al. Birth–death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV) , 2012, Proceedings of the National Academy of Sciences.
[39] Colin Simpson,et al. Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand , 2020, Nature Communications.
[40] O. Pybus,et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool , 2021, Virus evolution.
[41] R. Myers,et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant , 2021, The New England journal of medicine.
[42] M. Mulligan,et al. High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals , 2021, Cell Reports.
[43] I. Jaja,et al. Social distancing: how religion, culture and burial ceremony undermine the effort to curb COVID-19 in South Africa , 2020, Emerging microbes & infections.
[44] G. Wallau,et al. Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil , 2021, Frontiers in Microbiology.
[45] Trevor Bedford,et al. Nextstrain: real-time tracking of pathogen evolution , 2017, bioRxiv.
[46] G. Wallau,et al. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence , 2021, Nature Medicine.
[47] Colin Simpson,et al. Phylodynamics reveals the role of human travel and contact tracing in controlling COVID-19 in four island nations , 2020, medRxiv.
[48] Andrew Rambaut,et al. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen) , 2016, Virus evolution.
[49] Y. Liu,et al. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus , 2021, Journal of travel medicine.
[50] I. Majsterek,et al. The Emerging Concern and Interest SARS-CoV-2 Variants , 2021, Pathogens.
[51] A. Londei,et al. Ranking the effectiveness of worldwide COVID-19 government interventions , 2020, Nature Human Behaviour.
[52] Kazutaka Katoh,et al. Multiple alignment of DNA sequences with MAFFT. , 2009, Methods in molecular biology.
[53] R. Bouckaert,et al. bModelTest: Bayesian phylogenetic site model averaging and model comparison , 2015, BMC Evolutionary Biology.
[54] M. Lipsitch,et al. Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape , 2021, Cell.
[55] Ryan R. Wick,et al. Performance of neural network basecalling tools for Oxford Nanopore sequencing , 2019, Genome Biology.
[56] M. Roser,et al. Coronavirus Pandemic (COVID-19) , 2020 .
[57] S. Mattar,et al. Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved? , 2022, Tropical Diseases, Travel Medicine and Vaccines.
[58] Z. Cucunubá,et al. COVID-19 spread, detection, and dynamics in Bogota, Colombia , 2021, Nature Communications.
[59] H. van Bakel,et al. The arrival and spread of SARS‐CoV‐2 in Colombia , 2020, Journal of medical virology.
[60] M. Pallen,et al. SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse , 2021, Nature Microbiology.
[61] Alexei J. Drummond,et al. Bayesian Phylogeography Finds Its Roots , 2009, PLoS Comput. Biol..
[62] J. Quick. nCoV-2019 sequencing protocol v3 (LoCost) , 2020 .